Efficacy and Safety of Auricular Acupuncture in Depression During the Covid 19 Pandemic
Recruiting · NCT05855421 · Interventional (participants receive a specific treatment) · Lead sponsor: Universidade do Sul de Santa Catarina
View the official record on ClinicalTrials.gov →Interventions studied
Auricular Acupuncture
What this trial is about
Participants with moderate depressive symptoms measured by PHQ-9 will be randomized to receive auricular acupuncture. The triple blinded procedure will be conducted in 12 sessions (6 weeks). The primary outcome is the response to the treatment 3 months after inclusion.
Who can take part
Age range
18 Years to 50 Years
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Age between 18 and 50 years old
- PHQ-9 score between 10 and 19 (moderate depression)
- Availability for sessions
Exclusion criteria
- Use complementary and integrative practices at the last 3 months; Suicidal risk evaluated by question number 9 in the PHQ-9 Severe depression score in the PHQ-9 Prior use of auricular acupuncture Pregnancy Menopause Tape and metal allergy
Where it is running
1 location listed.
- Universidade do Sul de Santa Catarina - Palhoça, Santa Catarina, Brazil